The largest database of trusted experimental protocols

Protoscript m mulv

Manufactured by New England Biolabs
Sourced in United States

ProtoScript M-MuLV is a reverse transcriptase enzyme derived from Moloney Murine Leukemia Virus. It is used to catalyze the conversion of RNA to complementary DNA (cDNA) in reverse transcription reactions.

Automatically generated - may contain errors

2 protocols using protoscript m mulv

1

Gene Expression Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated from cells or tissues using TRIzol reagent (Invitrogen, Shanghai, China). cDNA for was synthesized using ProtoScript M-MuLV (NEB,USA). The DNA standards were performed using pspt18 vector (Promega, USA) as previously described40 (link), and primer sequences were listed in Supplementary Table 1. Real-time PCR was performed using SYBR Premix Ex TaqTM (TaKaRa, Dalian, China) on ABI StepOne Plus™ Real-Time PCR System (Applied Biosystems, USA). Relative expression was analyzed by using 2−ΔΔCt and are referred to the control treatment using RPLP0 as a reference gene. The primer sequences were listed in Supplementary Table 2.
+ Open protocol
+ Expand
2

Arterial RNA Extraction and qPCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from either whole arteries or ~ 200-300 isolated selected arterial myocytes using TRIzol (Life Technologies) or the Absolutely RNA Nanoprep kit (Stratagene), respectively. First-strand cDNA was generated from 1-5 ng of total RNA using Protoscript M-MULV (New England Biolabs). PCR was performed on first-strand cDNA using primers sequences shown in Online Table I. PCR products were separated on 1.5% agarose gels.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!